Journal
GYNECOLOGIC ONCOLOGY
Volume 112, Issue 2, Pages 301-306Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygyno.2008.10.004
Keywords
Epigenetic inactivation; Cervical cancer; SFRP genes
Categories
Funding
- National Science Council, Taiwan, Republic of China (ROC) [NSC95-2320-B-016-019-MY2, NSC96-3112-B-016-003, NSC97-3112-B016-002]
- Tri-Service General Hospital, Taiwan, ROC [TSGH-C95-7-S01, TSGH-C95-7-S02, TSGH-C95-7-S03, TSGH-C95-7-S04]
- Armed Forces Tao-Yuan General Hospital, Tao-Yuan, Taiwan, ROC [AFTYGH-9607, AFTYGH-9608]
- Department of Health, Taiwan, Republic of China [DOH97-TD-1-111-TM005]
Ask authors/readers for more resources
Objectives. Oncogenic activation of the Wnt/beta-catenin signaling pathway is common in human cancers, including cervical cancer. The secreted frizzled-related proteins (SFRPs) function as negative regulators of Wnt signaling and play an important role in carcinogenesis. Frequent promoter hypermethylation of SFRPs has been identified in human cancers; however, the precise role of SFRPs in cervical cancer is not clear. Methods. The methylation status of SFRPs gene family was analyzed in two cervical cancer cell lines and a full spectrum of cervical neoplasia, including 45 low-grade squamous intraepithelial lesions (LSIL), 49 high-grade squamous intraepithelial lesions (HSIL), 109 squamous cell carcinomas (SCC), and 45 normal controls. Results. The SFRP1 promoter was hypermethylated in 33.9% of SCC, 8.2% of HSIL, 2.2% of LSIL, but not in normal tissues. The SFRP2 promoter was hypermethylated in 80.7% of SCC, 16.3% of HSIL, 15.6% LSIL and 4.4% normal tissues. The SFRP4 promoter was hype methylated in 67.9% of SCC, 36.7% of HSIL, 4.4% of LSIL, but not in normal tissues. The SFRP5 promoter was hypermethylated in 10.1% of SCC, 4.1% of HSIL, 13.3% of LSIL and 4.4% normal tissues. The frequency of SFRP1, SFRP2 and SFRP4 promoter methylation in tumors was significantly higher than in normal, LSIL, and HSIL samples (P<0.0001). SFRP5 methylation was significantly different in patients with or without lymph-node metastases (0% vs 15.2%, respectively, P<0.05). Conclusions. Our data suggest that promoter hypermethylation of SFRP1, SFRP2 and SFRP4 is associated with cervical carcinogenesis, which could be used for molecular screening of cervical neoplasias in future. (C) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available